Newcourt Acquisition Corp

Status: Deal Closed
U=S+W/2 W=S@11.5
IPO Proceeds, $M $250.00M
IPO Date Oct 20, 2021
CEO Marc Balkin
Left Lead Cantor Fitzgerald
IPO Cash in Trust 102.0%
SPAC Tenor 15 + 6 + 6 + 1
IPO Sector Financial

Financial services and financial technology businesses with exposure to emerging markets

IPO Geography EEMEA
Target Company Psyence Biomed Corp
Deal Announced Jan 9, 2023
Deal Size, $M $111.00M
Deal Sector Healthcare
Deal Geography Global
SEC Filings www.sec.gov
Approval Vote Jan 18, 2024
Amendment Vote Jan 22, 2024
Closing Date Jan 25, 2024
Formerly NCAC PBM PBMWW

Sign up for Free Trial

No credit card required

Sign in for more on Newcourt Acquisition Corp:

  • Structure and cap table
  • 6 directors & officers
  • 45 filings and events
  • 1 underwriters
  • 1 deal advisors
  • 3 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Michael Jordaan 52 Chairman of the Board of Directors
Marc Balkin 47 CEO
Jurgen van de Vyver 34 CFO
Simran Aggarwal 48 Director
Rohit Bodas 45 Director
Nicole Farb 42 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Cantor Fitzgerald BR 22,000,000 units
22,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 5.00 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 45 filings.

Shareholders

Sign in to view shareholders 13F filing data.